Regeneron Pharmaceuticals said it will acquire 23andMe's business. What happened to 23andMe? Should you delete your data?

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction ...

Regeneron acquired 23andMe for $256M, gaining 15M DNA profiles to enhance R&D. Find out why REGN stock is a Buy.

Regeneron Pharmaceuticals has said it will preserve the privacy of 23andMe's genetic data after it acquires the DNA testing ...

Genetic testing company 23andMe is being acquired, shortly after it declared bankruptcy months ago.

The price tag of this acquisition suggests that the value of genetic data is declining. Back in 2018, the drug company GSK ...

Biotechnology leader Regeneron Pharmaceuticals is acquiring genetic testing firm 23andMe for $256 million following its ...

Attorney General Jeff Jackson announced that North Carolinians can file claims against a DNA testing company related to a ...

RALEIGH, N.C. (WITN) - The deadline to file claims against a DNA testing company has been announced. In October 2023, 23andMe ...

North Carolinians have until July 14th, to file claims against DNA testing company 23andMe for any general claims against the ...

Regeneron Pharmaceuticals enters into asset purchase agreement to acquire 23andMe for $256 million: Tarrytown, New York Wednesday, May 21, 2025, 13:00 Hrs [IST] Regeneron Pharmace ...

In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.